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D-Glucosamine is a useful medicament in various fields of medicine and dentistry. With respect to stability of the cell membrane,
it has been reported that bradykinin-induced nociceptive responses are significantly suppressed by the direct application of
D-glucosamine. Electroporation is usually used to effectively introduce foreign genes into tissue culture cells. Buffers for
electroporation with or without D-glucosamine are used in experiments of transfection vectors. This is the first study to indirectly
observe the stability and protection of the osteoblast membrane against both electric stress and gene uptake (the proton sponge
hypothesis: osmotic rupture during endosomes prior to fusion with lysosomes) in electroporation with D-glucosamine application.
The transfection efficiency was evaluated as the fluorescence intensity of the transfected green fluorescent protein (GFP) in the
cultured cells (osteoblasts; NOS-1 cells). The transfection efficiency increased over 30% in the electroporation samples treated with
D-glucosamine-supplemented buffer after one day. The membrane absorption of D-glucosamine is the primary mechanism of
membrane stress induced by electric stress. This new function of D-glucosamine is useful and meaningful for developing more
effective transformation procedures.
1. Introduction
D-Glucosamine is a useful medicament in various fields of
medicine and dentistry [1, 2]. For example, it is an attractive
candidate for adjunctive therapy in patients with arthritis due
to both its chondroprotective actions and anti-inflammatory
and wound healing effects achieved via the suppression of
the neutrophil function and chemokine production [3]. D-
Glucosamine also has a significant antipain effect in patients
with osteoarthritis. Therefore, D-glucosamine is widely used
in an attempt to suppress the pain associated with the
disability of osteoarthritis [4]. Recently, our group reported
that bradykinin-induced nociceptive responses were signifi-
cantly suppressed by the direct application of D-glucosamine
[5], suggesting that D-glucosamine has a direct effect in
relieving pain by ensuring membrane stability. Furthermore,
we previously reported that D-glucosamine hydrochloride
promoted the lysosomal escape of quantum dots inside cells
(unpublished data).
The aim of this study was to confirm the maintenance
of cell membrane stability via the direct effects of D-
glucosamine. We used the electroporation technique for
gene transfection as an experimental model to investigate
both membrane protection (stability) and gene protection. A
buffer solution with or without D-glucosamine was used in
electroporation of the transfection vector. The transfection
efficiency was quantitatively evaluated as the fluorescence
intensity of transfected green fluorescent protein (GFP) in the
cultured cells.
2. Materials and Methods
2.1. Preparation of Cultured Cells. Osteoblasts (NOS-1 cells
[6]) derived from human osteosarcoma were used and
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Figure 1: Wire type of electrode for electroporation.
cultured in 𝛼-MEM containing 10% FBS together with
antibiotics. One day before electroporation, the NOS-1 cells
were prepared to loose confluence in a 60mm culture dish.
After passage, the NOS-1 cells were seeded in a 35mm glass-
bottomed culture dish (number P35Gcol-1.5-14-C, MatTek
Corp., MA, USA) at a density of 5 × 105 cells (each group:
three dishes), and 𝛼-MEM containing 10% FBS without
antibiotics was used for culture in a humidified incubator at
37∘C in an atmosphere of 5% CO
2
and air.
2.2. Preparation of Chitosan Solution and Buffer. D-Glucos-
amine hydrochloride (molecular weight: approximately 215)
was kindly supplied by Koyo Chemical Co., Ltd (Osaka,
Japan). A 1% (W/V) stock solutionwas prepared by dissolving
powder in 0.1% (V/V) acetic acid. The completely dissolved
solution was neutralized to a pH value of 7.4, then sterilized
with a 0.2 𝜇m filter. Electroporation buffer with or without
0.005% (W/V)D-glucosamine in 𝛼-MEMwithout either FBS
or antibiotics was prepared for electroporation.
2.3. Procedures for Electroporation. Electroporation was per-
formed using a wire type electrode (Figure 1) that was
set vertical to the surface of the culture dish. One day
after passage, the cells attached on the culture dish were
treated using a commercial electroporator (CUY21B, Tokiwa
Science LimitedCompany, Fukuoka, Japan), connected to the
electrode. The pIRES2-EGFP vector (Clontech, Takara Bio
Company, Shiga, Japan) was used as an expression plasmid
during transfection. A total of 10 𝜇g/mL of the vector was
prepared by dissolving the vector in the buffer.The treatment
conditions consisted of five pulses of 120V (effective voltage:
40–70V, effective current: 40–4.4A), each on: 5ms and off:
95ms, in 1mL of electrode buffer with or without 0.005%
(W/V) D-glucosamine.
2.4. Fluorescence Microscopy. The cells were cultured with
𝛼-MEM without either FBS or antibiotics for one day after
electroporation and viewed using a confocal lasermicroscope
(TCS SL, Leica Microsystems GmbH,Wetzlar, Germany) at a
magnification of ×630.
2.5. Statistical Analysis. The number of GFP-positive cells
was counted and converted to a percentage of the origi-
nal cell number (100%) in three areas selected at random
from the examined group supplemented with or without
D-glucosamine. The statistical significance (𝑃 < 0.05) of
differences between the two groups was assessed using paired
Student’s t-test. All values are expressed as the mean ± SD.
3. Results
No necrotic cells were observed after electroporation treat-
ment. The percentage of GFP-positive cells was 86.4 ±
4.3% (Figures 2(a) and 2(b)) following electroporation
with 0.005% D-glucosamine-containing buffer and 48.7 ±
2.9% (Figures 3(a) and 3(b)) following that without D-
glucosamine-containing buffer. The transfection efficiency
increased approximately 38%. The percentage between the
two groups was significantly different (𝑃 < 0.01).
4. Discussion
This is the first study to observe the stability and protection
of the osteoblast membrane against electric stress and genes
against lysosomal attack during electroporation with D-
glucosamine application. This function of D-glucosamine is
relevant for cell biology and biological applications, such as
gene therapy.
D-Glucosamine is used as an effective medicament in
various fields of medicine and dentistry. For example, it is an
attractive candidate for adjunctive therapy in patients with
arthritis [7]. D-Glucosamine also has a significant antipain
effect in patients with osteoarthritis, a disease with low
expectations on the value of treatment [8, 9]. The membrane
absorption of D-glucosamine is the primary mechanism
of quantum dot (QD) transport into cells (unpublished
data). A dramatic increase in the cellular uptake of QDs
via attachment with the cell membrane is induced by
a positive charge and biocompatibility of conjugated D-
glucosamine. This phenomenon was confirmed in control
experiments, which clearly indicated that nonconjugated
QDshave difficulty entering cells. Another interesting finding
is the escape of QDs from lysosomes inside cells, which
was confirmed with the observation of merged fluorescence
of both QDs and lysosomes. The significant increase in
transfection efficiency observed in the present study using
D-glucosamine was likely produced by the same mecha-
nism as that underlying the observation of stability and
protection of intracellularly distributed QDs following D-
glucosamine application. This proton sponge hypothesis,
while not definitively proven, has been invoked to explain the
relatively high transfection efficiency of other proton-sponge-
type materials, such as lipopolyamines [10, 11], PAMAM
dendrimers [12], and various imidazole-containing polymers
[13–15]. The original hypothesis proposed that PEI buffering
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Figure 2: (a) GFP-positive cells after electroporation with 0.005%D-glucosamine-containing buffer. (b) Phase contrast image of area A. Scale
bar = 20 𝜇m.
(a) (b)
Figure 3: (a) GFP-positive cells after electroporation without 0.005% D-glucosamine-containing buffer. (b) Phase contrast image of area A.
Scale bar = 20 𝜇m.
in lysosomes induced osmotic rupture and subsequent escape
[16]. Although the proton sponge hypothesis based on their
findings of a lack of lysosomal involvement is challenged in
polyethylenimine- (PEI-) mediated gene transfer, a version
of this hypothesis, whereby PEI buffering induces osmotic
rupture in endosomes prior to fusion with lysosomes [10, 17],
is consistent with the findings of Godbey et al. [18]. Although
the pH value of D-glucosamine hydrochloride is acidic (3.5–
4.5), the present D-glucosamine solution was used after
neutralization. The concentration of endosomal chloride
ions originated from D-glucosamine hydrochloride leads to
osmotic rupture in endosomes [10, 16], which involves the
escape of plasmid vectors from endosomes and lysosomes.
The newly proven polycationic function of D-glucosamine
through the adsorption to cell membrane and accumulation
into cytoplasm (the proton sponge hypothesis: escape from
the degradative lysosomal trafficking pathway) is useful and
meaningful for both cell biology and clinical applications.
5. Conclusion
This is the first study to investigate the stability and protec-
tion of the osteoblast membrane against electric stress and
genes against lysosomal attack during electroporation with
D-glucosamine application. The newly proven polycationic
function of D-glucosamine (the proton sponge hypothesis:
escape from the degradative lysosomal trafficking pathway)
is useful and meaningful for both cell biology and clinical
applications.
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